Rocket


Overview
Financials
News + Filings
Key Docs
Ownership


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Ascendis Pharma A/S (ASND) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/11/2023 6-K Quarterly results
09/29/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "Articles of Association",
"Articles of Association"
09/27/2023 144 Form 144 - Report of proposed sale of securities:
09/26/2023 144 Form 144 - Report of proposed sale of securities:
08/09/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "Articles of Association",
"Articles of Association"
07/12/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "Articles of Association",
"Articles of Association"
06/30/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "Articles of Association",
"Articles of Association"
06/01/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K",
"Articles of Association"
05/31/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "Company Presentation",
"Company Presentation"
05/31/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K"
05/11/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "Articles of Association",
"Articles of Association"
05/10/2023 144 Form 144 - Report of proposed sale of securities:
05/05/2023 144 Form 144 - Report of proposed sale of securities:
05/01/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K"
04/27/2023 6-K Quarterly results
04/27/2023 6-K Quarterly results
04/03/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K"
03/15/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "Articles of Association",
"Articles of Association"
03/13/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K"
03/01/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K"
02/28/2023 S-8 Form S-8 - Securities to be offered to employees in employee benefit plans:
02/14/2023 SC 13G/A RA CAPITAL MANAGEMENT, L.P. has filed a Schedule 13D for Ascendis Pharma A/S
02/14/2023 SC 13G/A BAKER BROS. ADVISORS LP reports a 8.7% stake in Ascendis Pharma A/S
02/14/2023 SC 13G/A PRICE T ROWE ASSOCIATES INC reports a 6.5% stake in ASCENDIS PHARMA A/S - ADR
02/14/2023 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/10/2023 SC 13G/A JANUS HENDERSON GROUP PLC reports a 6.4% stake in Ascendis Pharma A/S
02/10/2023 SC 13G/A Artisan Partners Limited Partnership reports a 12.1% stake in Ascendis Pharma A/S
02/09/2023 SC 13G/A FMR LLC reports a 9.3% stake in ASCENDIS PHARMA AS
02/06/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
01/11/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "Articles of Association",
"Articles of Association"
01/09/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "Company Presentation",
"Company Presentation"
01/09/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "6-K"
01/03/2023 6-K Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs: "Articles of Association",
"Articles of Association"
12/14/2022 6-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy